Immune Response

  • Malaria Vaccine Primes Victims’ Blood to Eliminate Parasite From Mosquitoes
    Researchers at the National Institutes of Health have developed an experimental vaccine that could, theoretically, eliminate malaria from entire geographic regions, by eradicating the malaria parasite from an area's mosquitoes. The vaccine, so far tested only in mice, would ...More
    December 19, 2006 Posted in News
  • Clues Found on How Deadly Bacterium Gains Foothold
    How a potentially deadly bacterium that could be used as a bioterrorist tool eludes being killed by the human immune system is now better understood, University of Iowa researchers report in the December issue of the Journal of Leukocyte Biology. This bacterium, Francisella ...More
    December 19, 2006 Posted in News
  • Infectious Disease Researchers Develop Basis for Experimental Melanoma Treatment
    While investigating a fungus known to cause an infection in people with AIDS, two grantees of the National Institute of Allergy and Infectious Diseases (NIAID) unexpectedly discovered a potential strategy for treating metastatic melanoma, one of the deadliest forms of skin ...More
    December 8, 2006 Posted in News
  • New Study Finds On/Off Switch for Septic Shock
    According to a new study, septic shock, a dangerous, often deadly runaway immune response, is controlled by a genetic on/off switch. The research also suggests how a drug might temper sepsis. This is the first time this genetic mechanism has been revealed in an experimental ...More
    November 15, 2006 Posted in News
  • Lab-On-a-Chip Could Speed Up Treatment of Drug-Resistant Pneumonia
    The emergency treatment of drug-resistant infections with targeted antibiotics is often delayed by the need to identify bacterial strains by growing them in culture first. At this week's AVS 53rd International Symposium & Exhibition in San Francisco, Michael Lochhead, a ...More
    November 14, 2006 Posted in News
  • Drexel University’s Research in Cytokines Could Treat Sepsis
    Researchers from DrexelUniversity and the University of Brighton in the U.K. have achieved groundbreaking results, which may significantly improve the treatment of sepsis. Their paper, titled “Mesoporous Carbide-Derived Carbon with Porosity Tuned for Efficient Adsorption of ...More
    October 27, 2006 Posted in News
  • Experimental Vaccine Protects Mice Against Deadly 1918 Flu Virus
    Federal scientists have developed a vaccine that protects mice against the killer 1918 influenza virus. They also have created a technique for identifying antibodies that neutralize this virus, a tool that could help contain future pandemic flu strains. These findings are ...More
    October 19, 2006 Posted in News
  • FDA Approves Test to Help Diagnose Main Virus that Causes AIDS
    The U.S. Food and Drug Administration (FDA) has approved the APTIMA HIV-1 RNA Qualitative Assay, manufactured by Gen-Probe Incorporated of San Diego, Calif. The APTIMA assay, which detects the RNA--the nucleic acid or genetic material--of the HIV-1 virus, is the first test ...More
    October 5, 2006 Posted in News
  • Biodegradable Napkin Containing Sensitive Nanofibers May Quickly Detect Biohazards
    Detecting bacteria, viruses and other dangerous substances in hospitals, airplanes and other commonly contaminated places could soon be as easy as wiping a napkin or paper towel across a surface, says a researcher from Cornell University. “It’s very inexpensive, it wouldn’t ...More
    September 11, 2006 Posted in News
  • 'Nanocantilevers' Yield Surprises Critical for Designing New Detectors
    This rendition depicts an array of tiny, diving-boardlike devices called nanocantilevers. The devices are coated with antibodies to capture viruses, which are represented as red spheres. New findings about the behavior of the cantilevers could be crucial in designing a new ...More
    August 29, 2006 Posted in News